Hantavirus news28 May 2026 07:05
Physiomics Demonstrates Hantavirus Translational Modelling Capability
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to highlight the development of a hantavirus translational modelling framework demonstrating the Company's quantitative pharmacology and mechanistic modelling capabilities within infectious disease applications.
The framework illustrates how Physiomics can integrate multiple evidence layers into a coherent translational workflow, linking: